Daniela Manno

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Ensuring children's inclusion in the Bundibugyo Ebola response: Striving to do better this time.

Ensuring children's inclusion in the Bundibugyo Ebola response: Striving to do better this time.

Journal: PLOS global public health

Published: September 02, 2026

The DRC Ebola outbreak has exposed the consequences of global health underfunding.

The DRC Ebola outbreak has exposed the consequences of global health underfunding.

Journal: BMJ (Clinical research ed.)

Published: May 27, 2026

A One Health trial design to accelerate Lassa fever vaccines.

A One Health trial design to accelerate Lassa fever vaccines.

Journal: Nature medicine

Published: January 02, 2026

Regulator experiences of trials during Ebola epidemics in Sierra Leone, Guinea, and the Democratic Republic of the Congo.

Regulator experiences of trials during Ebola epidemics in Sierra Leone, Guinea, and the Democratic Republic of the Congo.

Journal: Tropical medicine & international health : TM & IH

Published: April 03, 2025

Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.

Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.

Journal: Vaccines

Published: May 16, 2024

Pregnancy and neonatal outcomes in Eastern Democratic Republic of the Congo: a systematic review.

Pregnancy and neonatal outcomes in Eastern Democratic Republic of the Congo: a systematic review.

Journal: Frontiers in global women's health

Published: April 04, 2024

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.

Journal: Vaccines

Published: October 26, 2023

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.

Journal: Vaccines

Published: July 01, 2023

Developing a vaccine against Sudan virus disease.

Developing a vaccine against Sudan virus disease.

Journal: The Lancet. Infectious diseases

Published: May 24, 2023

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

Journal: Vaccine

Published: May 23, 2023

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.

Journal: The Lancet. Global health

Published: April 21, 2023

Developing a vaccine against Marburg virus disease.

Developing a vaccine against Marburg virus disease.

Journal: Lancet (London, England)

Published: November 24, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026